Of course not. All i am saying is that is what the cash component alone is worth. Quite high compared to most biotechs. The value of the stock will need to reflect values assigned to their various pipeline drugs on top of that.
- Forums
- ASX - By Stock
- BNO
- 40M + 10M = 50M = 47c per share
40M + 10M = 50M = 47c per share, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)